Founded in 2006 and based in Santa Barbara, California, Affinity Biosensors is dedicated to developing and manufacturing advanced analytical instruments for research, manufacturing, and life sciences. The company's core mission is to provide rapid and accurate diagnostic tools to combat rising antimicrobial resistance. Their flagship product, the LifeScale system, leverages Resonant Mass Measurement technology to offer unique and swift techniques for measuring and observing microbe growth and response.
Notable figures affiliated with Affinity Biosensors include its founding team of scientists and engineers who have driven innovation in electronic measuring equipment. The company has achieved significant milestones, including FDA clearance for the LifeScale AST system, which enhances diagnostic speed and accuracy in clinical settings. Affinity Biosensors' impact is evident in its contribution to faster diagnostics, which is crucial in addressing global health challenges such as antimicrobial resistance.